ALYSSA HAGY: Open Payments
NPI 1649044629 · STROUDSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 54 payments from 11 companies in 2025. Trend: 2023 $173 · 2024 $1,488 · 2025 $1,007
Food & beverage: $1,007
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $177 |
| Janssen Pharmaceuticals, Inc | 9 | $169 |
| Neurocrine BioSciences, Inc. | 8 | $168 |
| Lundbeck LLC | 6 | $117 |
| Alkermes, Inc. | 4 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| Vanda Pharmaceuticals Inc. | 3 | $49 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: REXULTI, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, TRINTELLIX, FANAPT, UZEDY.
Industry payments across PA — which companies pay providers there.
